The incidence of heparin-induced thrombocytopenia Type II in patients with subarachnoid hemorrhage treated with heparin versus enoxaparin: Clinical article

Journal of Neurosurgery

Volumn 110, Issue 1, 2009, Pages 50-57

  Kim, Grace H ^a   Hahn, David K ^a   Kellner, Christopher P ^a   Komotar, Ricardo J ^a   Starke, Robert ^a   Garrett, Matthew C ^a   Yao, Jiang ^a   Cleveland, Justin ^a   Mayer, Stephan A ^a   Connolly Jr , E Sander ^a  

^a College of Physicians and Surgeons ^*  (United States)

Author keywords

Enoxaparin; Heparin; Heparin induced thrombocytopenia; Subarachnoid hemorrhage

Indexed keywords

ENOXAPARIN; HEPARIN; ANTICOAGULANT AGENT;

ADULT; AGED; ANGIOGRAPHY; ARTICLE; CONTROLLED STUDY; FEMALE; HEPARIN INDUCED THROMBOCYTOPENIA; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; PRIORITY JOURNAL; RISK REDUCTION; SUBARACHNOID HEMORRHAGE; THROMBOSIS; THROMBOSIS PREVENTION; BRAIN ANGIOGRAPHY; CHEMICALLY INDUCED DISORDER; COHORT ANALYSIS; COMPARATIVE STUDY; COMPUTER ASSISTED TOMOGRAPHY; MIDDLE AGED; PROSPECTIVE STUDY; THROMBOCYTOPENIA; THROMBOEMBOLISM;

AGED; ANTICOAGULANTS; CEREBRAL ANGIOGRAPHY; COHORT STUDIES; ENOXAPARIN; FEMALE; HEPARIN; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; SUBARACHNOID HEMORRHAGE; THROMBOCYTOPENIA; THROMBOEMBOLISM; TOMOGRAPHY, X-RAY COMPUTED;

EID: 60749102417     PISSN: 00223085     EISSN: 19330693     Source Type: Journal    
DOI: 10.3171/2008.3.17480     Document Type: Article

References (57)

1. Agnelli G, Piovella F, Buoncristiani P, Severi P, Pini M, D'Angelo A, et al: Enoxaparin plus compression stockings compared with compression stockings alone in the prevention of venous thromboembolism after elective neurosurgery. N Engl J Med 339:80-85, 1998 (Pubitemid 28304882)
2. Almeida JI, Coats R, Liem TK, Silver D: Reduced morbidity and mortality rates of the heparin-induced thrombocytopenia syndrome. J Vasc Surg 27:309-316, 1998 (Pubitemid 28136811)
3. Amiral J, Bridey F, Dreyfus M, Vissoc AM, Fressinaud E, Wolf M, et al: Platelet factor 4 complexed to heparin is the target for antibodies generated in heparin-induced thrombocytopenia. Thromb Haemost 68:95-96, 1992
4. Antman EM, Morrow DA, McCabe CH, Murphy SA, Ruda M, Sadowski Z, et al: Enoxaparin versus unfractionated heparin with fibrinolysis for ST-elevation myocardial infarction. N Engl J Med 354:1477-1488, 2006
5. Baglin TP: Heparin induced thrombocytopenia thrombosis (HIT/T) syndrome: diagnosis and treatment. J Clin Pathol 54:272-274, 2001
6. Black PM, Baker MF, Snook CP: Experience with external pneu matic calf compression in neurology and neurosurgery. Neurosurgery 18:440-444, 1986
7. Brieger DB, Mak KH, Kottke-Marchant K, Topol EJ: Heparin-induced thrombocytopenia. J Am Coll Cardiol 31:1449-1459, 1998 (Pubitemid 28273284)
8. Chibbaro S, Tacconi L: Safety of deep venous thrombosis prophylaxis with low-molecular-weight heparin in brain surgery. Prospective study on 746 patients. Surg Neurol [epub ahead of print], 2008
9. Chong BH: Heparin-induced thrombocytopenia. Br J Haematol 89:431-439, 1995
10. Chong BH, Castaldi PA: Heparin-induced thrombocytopenia: further studies of the effects of heparin-dependent antibodies on platelets. Br J Haematol 64:347-354, 1986
11. Chong BH, Castaldi PA: Platelet proaggregating effect of heparin: possible mechanism for non-immune heparin-associated thrombocytopenia. Aust N Z J Med 16:715-716, 1986
12. Chong BH, Fawaz I, Chesterman CN, Berndt MC: Heparin-induced thrombocytopenia: mechanism of interaction of the heparin-dependent antibody with platelets. Br J Haematol 73:235-240, 1989 (Pubitemid 19256118)
13. Chong BH, Grace CS, Rozenberg MC: Heparin-induced thrombocytopenia: effect of heparin platelet antibody on platelets. Br J Haematol 49:531-540, 1981
14. Chong BH, Pitney WR, Castaldi PA: Heparin-induced thrombocytopenia: association of thrombotic complications with heparin-dependent IgG antibody that induces thromboxane synthesis in platelet aggregation. Lancet 2:1246-1249, 1982
15. Cines DB, Kaywin P, Bina M, Tomaski A, Schreiber AD: Heparin-associated thrombocytopenia. N Engl J Med 303:788-795, 1980 (Pubitemid 10002378)
16. Creekmore FM, Oderda GM, Pendleton RC, Brixner DI: Incidence and economic implications of heparin-induced thrombocytopenia in medical patients receiving prophylaxis for ve nous thromboembolism. Pharmacotherapy 26:1438-1445, 2006
17. Doty JR, Alving BM, McDonnell DE, Ondra SL: Heparin-associated thrombocytopenia in the neurosurgical patient. Neurosurgery 19:69-72, 1986
18. Fabris F, Ahmad S, Cella G, Jeske WP, Walenga JM, Fareed J: Pathophysiology of heparin-induced thrombocytopenia. Clinical and diagnostic implications - a review. Arch Pathol Lab Med 124:1657-1666, 2000
19. Fabris F, Luzzatto G, Stefani PM, Girolami B, Cella G, Girolami A: Heparin-induced thrombocytopenia. Haematologica 85:72-81, 2000 (Pubitemid 30096895)
20. Frim DM, Barker FG II, Poletti CE, Hamilton AJ: Postoperative low-dose heparin decreases thromboembolic complications in neurosurgical patients. Neurosurgery 30:830-833, 1992
21. Ganzer D, Gutezeit A, Mayer G: [Potentials risks in drug prevention of thrombosis-low-molecular-weight heparin versus standard heparin.] Z Orthop Ihre Grenzgeb 137:457-461, 1999 (Ger)
22. Gerlach R, Scheuer T, Beck J, Woszczyk A, Seifert V, Raabe A: Risk of postoperative hemorrhage after intracranial surgery after early nadroparin administration: results of a prospective study. Neurosurgery 53:1028-1035, 2003 (Pubitemid 37420951)
23. Girolami B, Prandoni P, Stefani PM, Tanduo C, Sabbion P, Eichler P, et al: The incidence of heparin-induced thrombocytopenia in hospitalized medical patients treated with subcutaneous unfractionated heparin: a prospective cohort study. Blood 101:2955-2959, 2003 (Pubitemid 36857979)
24. Greinacher A: Antigen generation in heparin-associated thrombocytopenia: the nonimmunologic type and the immunologic type are closely linked in their pathogenesis. Semin Thromb Hemost 21:106-116, 1995
25. Greinacher A, Eichler P, Lietz T, Warkentin TE: Replacement of unfractionated heparin by low-molecular-weight heparin for postorthopedic surgery antithrombotic prophylaxis lowers the overall risk of symptomatic thrombosis because of a lower frequency of heparin-induced thrombocytopenia. Blood 106:2921-2922, 2005 (Pubitemid 41510775)
26. Greinacher A, Farner B, Kroll H, Kohlmann T, Warkentin TE, Eichler P: Clinical features of heparin-induced thrombocytopenia including risk factors for thrombosis. A retrospective analysis of 408 patients. Thromb Haemost 94:132-135, 2005 (Pubitemid 40974717)
27. Greinacher A, Potzsch B, Amiral J, Dummel V, Eichner A, Mueller-Eckhardt C: Heparin-associated thrombocytopenia: isolation of the antibody and characterization of a multimolecular PF4-heparin complex as the major antigen. Thromb Haemost 71:247-251, 1994 (Pubitemid 24047336)
28. Hamilton MG, Hull RD, Pineo GF: Venous thromboembolism in neurosurgery and neurology patients: a review. Neurosurgery 34:280-296, 1994
29. Harbrecht U, Bastians B, Kredteck A, Hanfland P, Klockgether T, Pohl C: Heparin-induced thrombocytopenia in neurologic disease treated with unfractionated heparin. Neurology 62:657-659, 2004 (Pubitemid 38252817)
30. Hoh BL, Aghi M, Pryor JC, Ogilvy CS: Heparin-induced thrombocytopenia Type II in subarachnoid hemorrhage patients: incidence and complications. Neurosurgery 57:243-248, 2005 (Pubitemid 41098687)
31. Januzzi JL Jr, Jang IK: Heparin induced thrombocytopenia: diagnosis and contemporary antithrombin management. J Thromb Thrombolysis 7:259-264, 1999
32. Kelton JG, Smith JW, Warkentin TE, Hayward CP, Denomme GA, Horsewood P: Immunoglobulin G from patients with heparin-induced thrombocytopenia binds to a complex of heparin and platelet factor 4. Blood 83:3232-3239, 1994
33. Kongable GL, Lanzino G, Germanson TP, Truskowski LL, Alves WM, Torner JC, et al: Gender-related differences in aneurysmal subarachnoid hemorrhage. J Neurosurg 84:43-48, 1996 (Pubitemid 26006995)
34. Lewis BE, Wallis DE, Berkowitz SD, Matthai WH, Fareed J, Walenga JM, et al: Argatroban anticoagulant therapy in patients with heparin-induced thrombocytopenia. Circulation 103:1838-1843, 2001 (Pubitemid 32328395)
35. Leyvraz PF, Bachmann F, Hoek J, Buller HR, Postel M, Samama M, et al: Prevention of deep vein thrombosis after hip replacement: randomised comparison between unfractionated heparin and low molecular weight heparin. BMJ 303:543-548, 1991
36. Locke CF, Dooley J, Gerber J: Rates of clinically apparent heparin-induced thrombocytopenia for unfractionated heparin vs. low molecular weight heparin in non-surgical patients are low and similar. Thromb J 3:4, 2005 (Pubitemid 41529044)
37. Lubenow N, Eichler P, Lietz T, Greinacher A: Lepirudin in patients with heparin-induced thrombocytopenia - results of the third prospective study (HAT-3) and a combined analysis of HAT-1, HAT-2, and HAT-3. J Thromb Haemost 3:2428-2436, 2005 (Pubitemid 41727158)
38. Mahlfeld K, Franke J, Schaeper O, Kayser R, Grasshoff H: [Heparin-induced thrombocytopenia as a complication of postoperative prevention of thromboembolism with unfractionated heparin/low molecular weight heparin after hip and knee prosthesis implantation.] Unfallchirurg 105:327-331, 2002 (Ger)
39. Martel N, Lee J, Wells PS: Risk for heparin-induced thrombocytopenia with unfractionated and low-molecular-weight heparin thromboprophylaxis: a meta-analysis. Blood 106:2710-2715, 2005 (Pubitemid 41510744)
40. Nurmohamed MT, Rosendaal FR, Buller HR, Dekker E, Hommes DW, Vandenbroucke JP, et al: Low-molecular-weight heparin versus standard heparin in general and orthopaedic surgery: a meta-analysis. Lancet 340:152-156, 1992
41. Parney IF, Steinke DE: Heparin-induced thrombocytopenia and thrombosis following subarachnoid hemorrhage. Case report. J Neurosurg 93:136-139, 2000
42. Pohl C, Kredteck A, Bastians B, Hanfland P, Klockgether T, Harbrecht U: Heparin-induced thrombocytopenia in neurologic patients treated with low-molecular-weight heparin. Neurology 64:1285-1287, 2005 (Pubitemid 40490540)
43. Pouplard C, May MA, Iochmann S, Amiral J, Vissac AM, Marchand M, et al: Antibodies to platelet factor 4-heparin after cardiopulmonary bypass in patients anticoagulated with unfractionated heparin or a low-molecular-weight heparin: clinical implications for heparin-induced thrombocytopenia. Circulation 99:2530-2536, 1999 (Pubitemid 29228283)
44. Roberts B, Rosato FE, Rosato EF: Heparin - a cause of arterial emboli? Surgery 55:803-808, 1964
45. Rogers LA: Postendarterectomy heparin-induced thrombocytopenia. Case report. J Neurosurg 69:632-634, 1988
46. Schmitt BP, Adelman B: Heparin-associated thrombocytopenia: a critical review and pooled analysis. Am J Med Sci 305:208-215, 1993
47. Szucs TD, Schramm W: The cost-effectiveness of low-molecular- weight heparin vs unfractionated heparin in general and orthopaedic surgery: an analysis for the German healthcare system. Pharmacol Res 40:83-89, 1999
48. Walenga JM, Jeske WP, Prechel MM, Bacher P, Bakhos M: Decreased prevalence of heparin-induced thrombocytopenia with low-molecular-weight heparin and related drugs. Semin Thromb Hemost 30 (1 Suppl):69-80, 2004 (Pubitemid 38453585)
49. Wallis DE, Lewis BE, Walenga JM: Failure of current strategies in the prevention of thrombosis in patients with heparin-induced thrombocytopenia: a clinician's perspective. Semin Thromb Hemost 25 (1 Suppl):3-7, 1999
50. Warkentin TE, Cook DJ: Heparin, low molecular weight heparin, and heparin-induced thrombocytopenia in the ICU. Crit Care Clin 21:513-529, 2005
51. Warkentin TE, Greinacher A: Heparin-induced thrombocytopenia: recognition, treatment, and prevention: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 126 (3 Suppl):311S-337S, 2004
52. Warkentin TE, Kelton JG: A 14-year study of heparin-induced thrombocytopenia. Am J Med 101:502-507, 1996
53. Warkentin TE, Kelton JG: Temporal aspects of heparin-induced thrombocytopenia. N Engl J Med 344:1286-1292, 2001
54. Warkentin TE, Levine MN, Hirsh J, Horsewood P, Roberts RS, Gent M, et al: Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin. N Engl J Med 332:1330-1335, 1995
55. Warkentin TE, Roberts RS, Hirsh J, Kelton JG: An improved definition of immune heparin-induced thrombocytopenia in postoperative orthopedic patients. Arch Intern Med 163:2518-2524, 2003 (Pubitemid 37385796)
56. Warkentin TE, Sheppard JA, Horsewood P, Simpson PJ, Moore JC, Kelton JG: Impact of the patient population on the risk for heparin-induced thrombocytopenia. Blood 96:1703-1708, 2000 (Pubitemid 30661052)
57. Weismann RE, Tobin RW: Arterial embolism occurring during systemic heparin therapy. AMA Arch Surg 76:219-227, 1958